Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of a Short and Effective MRI Surveillance (SMS) Protocol for Hepatocellular Carcinoma Screening in Practice

NCT05429190 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT05429190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05429190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of a Short and Effective MRI Surveillance (SMS) Protocol for Hepatocellular Carcinoma Screening in Practice
Lead sponsor
Erasmus Medical Center
Phase
Observational
Overall status
Unknown status
Start date
November 7, 2023
Completion date
June 1, 2026
Enrollment
470 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma